Results 171 to 180 of about 1,412,519 (351)
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
Pharmacogenomics: candidate gene identification, functional validation and mechanisms [PDF]
Liguo Wang, Richard M. Weinshilboum
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
New candidate gene mutations in astrocytoma with seizures. [PDF]
Choochuen P +5 more
europepmc +1 more source
Cryptosporidium hominisgene catalog: a resource for the selection of novelCryptosporidiumvaccine candidates [PDF]
Olukemi O. Ifeonu +10 more
openalex +1 more source
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez +12 more
wiley +1 more source
Identification of CASKIN2 as a Novel Candidate Gene for Müllerian Duct Anomalies in Humans. [PDF]
Wang J, Xing Q, Yang Y, Yin R, Cao Y.
europepmc +1 more source

